Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Narlumosbart (JMT103) in Patients With Giant Cell Tumor of Bone [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating efficacy and safety of Narlumosbart (JMT103) in patients with giant cell tumor of bone.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Giant Cell Tumor of Bone

Drugs mentioned

• Narlumosbart (JMT103) (Narlumosbart)

Snippet

Sponsor: Shanghai JMT-Bio Inc. | Conditions: Giant Cell Tumor of Bone | Phase 3 | Status: NOT_YET_RECRUITING